31I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (IPAX-2)
NCT 05450744 Brief Summary This is an open label, single arm,…
Read more arrow_forwardNCT 05450744 Brief Summary This is an open label, single arm,…
Read more arrow_forwardNCT 05923008 Brief Summary This is a phase 1/2 multicenter, open-label, first-in-human…
Read more arrow_forwardNCT 05763004 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 05858164 Brief Summary Researchers are looking for a better way…
Read more arrow_forwardNCT 05999994 Brief Summary The main purpose of the master is to…
Read more arrow_forwardNCT 06170190 Brief Summary This is a multicentre, open-label, first-in-human, phase 1/2…
Read more arrow_forwardNCT 05332574 Brief Summary This is a Phase 1/2 study of GB263T…
Read more arrow_forwardNCT 05981703 Brief Summary This is an open-label, multicenter, and nonrandomized dose…
Read more arrow_forwardNCT 05381909 Brief Summary This study aims to understand how safe and…
Read more arrow_forwardNCT 05935098 Brief Summary This study aims to test the safety, tolerability,…
Read more arrow_forward